Deal signals plans for ‘sustainable’ bio-synthesised CBD

The commercialisation of bio-synthesised cannabidiol could be on the horizon following the announcement by Amyris that it will be forming a new partnership to focus on “cannabinoid development”. The California-based company is best known for creating synthetic sweeteners and medicines from sugars using a yeast-based process, and it is thought it will do the same […] ...

Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Erik Galavis
+34 654 320 547
Email Erik

Pablo Sharrock
+34 722 642 678
Email Pablo